223 related articles for article (PubMed ID: 22911550)
61. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou N; Ntoufa S; Tsagiopoulou M; Moysiadis T; Bhoi S; Malousi A; Psomopoulos F; Mansouri L; Laidou S; Papazoglou D; Gounari M; Pasentsis K; Plevova K; Kuci-Emruli V; Duran-Ferrer M; Davis Z; Ek S; Rossi D; Gaidano G; Ritgen M; Oscier D; Stavroyianni N; Pospisilova S; Davi F; Ghia P; Hadzidimitriou A; Belessi C; Martin-Subero JI; Pott C; Rosenquist R; Stamatopoulos K
Int J Cancer; 2019 Jun; 144(11):2695-2706. PubMed ID: 30447004
[TBL] [Abstract][Full Text] [Related]
62. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
63. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia.
Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ
Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134
[TBL] [Abstract][Full Text] [Related]
64. Single-Cell Analysis and Next-Generation Immuno-Sequencing Show That Multiple Clones Persist in Patients with Chronic Lymphocytic Leukemia.
Kriangkum J; Motz SN; Mack T; Beiggi S; Baigorri E; Kuppusamy H; Belch AR; Johnston JB; Pilarski LM
PLoS One; 2015; 10(9):e0137232. PubMed ID: 26353109
[TBL] [Abstract][Full Text] [Related]
65. Allelotyping in B-cell chronic lymphocytic leukemia (B-CLL).
Novak U; Tobler A; Fey MF
Leuk Lymphoma; 2004 May; 45(5):887-96. PubMed ID: 15291345
[TBL] [Abstract][Full Text] [Related]
66. Chronic lymphocytic leukemia: looking into the dark side of the genome.
Valdés-Mas R; Gutiérrez-Abril J; Puente XS; López-Otín C
Cell Death Differ; 2016 Jan; 23(1):7-9. PubMed ID: 26611460
[No Abstract] [Full Text] [Related]
67. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.
Kantorova B; Malcikova J; Smardova J; Pavlova S; Trbusek M; Tom N; Plevova K; Tichy B; Truong S; Diviskova E; Kotaskova J; Oltova A; Patten N; Brychtova Y; Doubek M; Mayer J; Pospisilova S
Tumour Biol; 2015 May; 36(5):3371-80. PubMed ID: 25527155
[TBL] [Abstract][Full Text] [Related]
68. Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients.
Subhash S; Kanduri M
J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654059
[TBL] [Abstract][Full Text] [Related]
69. The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.
Malek SN
Oncogene; 2013 Jun; 32(23):2805-17. PubMed ID: 23001040
[TBL] [Abstract][Full Text] [Related]
70. Genetic and epigenetic basis of chronic lymphocytic leukemia.
Martín-Subero JI; López-Otín C; Campo E
Curr Opin Hematol; 2013 Jul; 20(4):362-8. PubMed ID: 23719185
[TBL] [Abstract][Full Text] [Related]
71. Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications.
Hengeveld PJ; Levin MD; Kolijn PM; Langerak AW
Exp Hematol; 2021 Jan; 93():14-24. PubMed ID: 32976948
[TBL] [Abstract][Full Text] [Related]
72. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
[TBL] [Abstract][Full Text] [Related]
73. DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains.
Hernández-Sánchez M; Rodríguez-Vicente AE; González-Gascón Y Marín I; Quijada-Álamo M; Hernández-Sánchez JM; Martín-Izquierdo M; Hernández-Rivas JÁ; Benito R; Hernández-Rivas JM
Exp Hematol; 2019 Apr; 72():9-13. PubMed ID: 30807786
[TBL] [Abstract][Full Text] [Related]
74. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
Fais F; Ghiotto F; Hashimoto S; Sellars B; Valetto A; Allen SL; Schulman P; Vinciguerra VP; Rai K; Rassenti LZ; Kipps TJ; Dighiero G; Schroeder HW; Ferrarini M; Chiorazzi N
J Clin Invest; 1998 Oct; 102(8):1515-25. PubMed ID: 9788964
[TBL] [Abstract][Full Text] [Related]
75. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
Sutton LA; Rosenquist R
Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
[TBL] [Abstract][Full Text] [Related]
76. Analysis of VH251 gene mutation in chronic lymphocytic leukemia (CLL) and normal B-cell subsets.
Cai J; Humphries C; Lutz C; Tucker PW
Ann N Y Acad Sci; 1992 May; 651():384-92. PubMed ID: 1599132
[TBL] [Abstract][Full Text] [Related]
77. Dissecting CLL through high-dimensional single-cell technologies.
Gohil SH; Wu CJ
Blood; 2019 Mar; 133(13):1446-1456. PubMed ID: 30728142
[TBL] [Abstract][Full Text] [Related]
78. CLL clonal heterogeneity: an ecology of competing subpopulations.
Wu CJ
Blood; 2012 Nov; 120(20):4117-8. PubMed ID: 23160186
[No Abstract] [Full Text] [Related]
79. Gene mutations in chronic lymphocytic leukemia.
Amin NA; Malek SN
Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
[TBL] [Abstract][Full Text] [Related]
80. Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies.
Kikushige Y
J Clin Exp Hematop; 2020 Dec; 60(4):146-158. PubMed ID: 33148933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
